{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T04:36:35Z","timestamp":1793248595636,"version":"4.5.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China,China","doi-asserted-by":"crossref","award":["No.82402850"],"award-info":[{"award-number":["No.82402850"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China,China","doi-asserted-by":"crossref","award":["No.82402850"],"award-info":[{"award-number":["No.82402850"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China,China","doi-asserted-by":"crossref","award":["No.82402850"],"award-info":[{"award-number":["No.82402850"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China,China","doi-asserted-by":"crossref","award":["No.82402850"],"award-info":[{"award-number":["No.82402850"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China,China","doi-asserted-by":"crossref","award":["No.82402850"],"award-info":[{"award-number":["No.82402850"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"DOI":"10.1186\/s13075-025-03588-7","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T12:31:19Z","timestamp":1750336279000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["RTA 408 attenuates TBHP-Induced apoptosis in nucleus pulposus cells via Nrf2\/ARE and NF-\u03baB signaling pathways: in vitro and in vivo evidence for mitigating rats\u2019 intervertebral disc degeneration"],"prefix":"10.1186","volume":"27","author":[{"given":"Weibin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Defang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jichang","family":"Fei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengxuan","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingmin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengxin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,19]]},"reference":[{"issue":"7555","key":"3588_CR1","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1136\/bmj.332.7555.1430","volume":"332","author":"BW Koes","year":"2006","unstructured":"Koes BW, van Tulder MW, Thomas S. Diagnosis and treatment of low back pain. BMJ. 2006;332(7555):1430\u20134.","journal-title":"BMJ"},{"issue":"10267","key":"3588_CR2","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1016\/S0140-6736(20)32340-0","volume":"396","author":"A Cieza","year":"2020","unstructured":"Cieza A, Causey K, Kamenov K, Hanson SW, Chatterji S, Vos T. Global estimates of the need for rehabilitation based on the global burden of disease study 2019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396(10267):2006\u201317.","journal-title":"Lancet"},{"issue":"10258","key":"3588_CR3","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"T Vos","year":"2020","unstructured":"Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396(10258):1204\u201322.","journal-title":"Lancet"},{"issue":"4","key":"3588_CR4","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1097\/00007632-200002150-00016","volume":"25","author":"K Luoma","year":"2000","unstructured":"Luoma K, Riihim\u00e4ki H, Luukkonen R, Raininko R, Viikari-Juntura E, Lamminen A. Low back pain in relation to lumbar disc degeneration. Spine (Phila Pa 1976). 2000;25(4):487\u201392.","journal-title":"Spine (Phila Pa 1976)"},{"issue":"8","key":"3588_CR5","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1097\/BRS.0b013e31822b01bd","volume":"37","author":"A Becker","year":"2012","unstructured":"Becker A, Held H, Redaelli M, Chenot JF, Leonhardt C, Keller S, et al. Implementation of a guideline for low back pain management in primary care: a cost-effectiveness analysis. Spine (Phila Pa 1976). 2012;37(8):701\u201310.","journal-title":"Spine (Phila Pa 1976)"},{"key":"3588_CR6","doi-asserted-by":"crossref","unstructured":"Akanji MA, Rotimi DE, Elebiyo TC, Awakan OJ, Adeyemi OS. Redox Homeostasis and Prospects for Therapeutic Targeting in Neurodegenerative Disorders. Hannibal L, editor. Oxidative Medicine and Cellular Longevity. 2021;2021:1\u201314.","DOI":"10.1155\/2021\/9971885"},{"issue":"1","key":"3588_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.7150\/thno.48987","volume":"11","author":"A Kamali","year":"2021","unstructured":"Kamali A, Ziadlou R, Lang G, Pfannkuche J, Cui S, Li Z, et al. Small molecule-based treatment approaches for intervertebral disc degeneration: current options and future directions. Theranostics. 2021;11(1):27\u201347.","journal-title":"Theranostics"},{"issue":"7","key":"3588_CR8","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/s41419-019-1701-3","volume":"10","author":"Z Tang","year":"2019","unstructured":"Tang Z, Hu B, Zang F, Wang J, Zhang X, Chen H. Nrf2 drives oxidative stress-induced autophagy in nucleus pulposus cells via a Keap1\/Nrf2\/p62 feedback loop to protect intervertebral disc from degeneration. Cell Death Dis. 2019;10(7):510.","journal-title":"Cell Death Dis"},{"key":"3588_CR9","doi-asserted-by":"publisher","first-page":"e52570","DOI":"10.7554\/eLife.52570","volume":"9","author":"H Che","year":"2020","unstructured":"Che H, Li J, Li Y, Ma C, Liu H, Qin J, et al. p16 deficiency attenuates intervertebral disc degeneration by adjusting oxidative stress and nucleus pulposus cell cycle. Elife. 2020;9:e52570.","journal-title":"Elife"},{"key":"3588_CR10","doi-asserted-by":"publisher","first-page":"101559","DOI":"10.1016\/j.mcp.2020.101559","volume":"51","author":"Y Lu","year":"2020","unstructured":"Lu Y, Zhou L, He S, Ren HL, Zhou N, Hu ZM. Lycopene alleviates disc degeneration under oxidative stress through the Nrf2 signaling pathway. Mol Cell Probes. 2020;51:101559.","journal-title":"Mol Cell Probes"},{"issue":"1","key":"3588_CR11","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1101\/gad.13.1.76","volume":"13","author":"K Itoh","year":"1999","unstructured":"Itoh K, Wakabayashi N, Katoh Y, Ishii T, Igarashi K, Engel JD, et al. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev. 1999;13(1):76\u201386.","journal-title":"Genes Dev"},{"issue":"1","key":"3588_CR12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13024-021-00479-8","volume":"16","author":"S Bono","year":"2021","unstructured":"Bono S, Feligioni M, Corbo M. Impaired antioxidant KEAP1-NRF2 system in amyotrophic lateral sclerosis: NRF2 activation as a potential therapeutic strategy. Mol Neurodegener. 2021;16(1):71.","journal-title":"Mol Neurodegener"},{"key":"3588_CR13","doi-asserted-by":"publisher","first-page":"101149","DOI":"10.1016\/j.redox.2019.101149","volume":"22","author":"L Tian","year":"2019","unstructured":"Tian L, Lu Y, Yang T, Deng Z, Xu L, Yao W, et al. aPKC\u03b9 promotes gallbladder cancer tumorigenesis and gemcitabine resistance by competing with Nrf2 for binding to Keap1. Redox Biol. 2019;22:101149.","journal-title":"Redox Biol"},{"key":"3588_CR14","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.freeradbiomed.2021.12.001","volume":"179","author":"QM Chen","year":"2022","unstructured":"Chen QM. Nrf2 for protection against oxidant generation and mitochondrial damage in cardiac injury. Free Radic Biol Med. 2022;179:133\u201343.","journal-title":"Free Radic Biol Med"},{"issue":"8","key":"3588_CR15","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/s12276-022-00829-6","volume":"54","author":"Q Xiang","year":"2022","unstructured":"Xiang Q, Zhao Y, Lin J, Jiang S, Li W. The Nrf2 antioxidant defense system in intervertebral disc degeneration: molecular insights. Exp Mol Med. 2022;54(8):1067\u201375.","journal-title":"Exp Mol Med"},{"issue":"5","key":"3588_CR16","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s00403-013-1433-7","volume":"306","author":"SA Reisman","year":"2014","unstructured":"Reisman SA, Lee CYI, Meyer CJ, Proksch JW, Ward KW. Topical application of the synthetic triterpenoid RTA 408 activates Nrf2 and induces cytoprotective genes in rat skin. Arch Dermatol Res. 2014;306(5):447\u201354.","journal-title":"Arch Dermatol Res"},{"issue":"2","key":"3588_CR17","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1124\/pr.117.014753","volume":"70","author":"A Cuadrado","year":"2018","unstructured":"Cuadrado A, Manda G, Hassan A, Alcaraz MJ, Barbas C, Daiber A, et al. Transcription factor NRF2 as a therapeutic target for chronic diseases: A systems medicine approach. Pharmacol Rev. 2018;70(2):348\u201383.","journal-title":"Pharmacol Rev"},{"key":"3588_CR18","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.2147\/DDDT.S193889","volume":"13","author":"SA Reisman","year":"2019","unstructured":"Reisman SA, Gahir SS, Lee CYI, Proksch JW, Sakamoto M, Ward KW. Pharmacokinetics and pharmacodynamics of the novel Nrf2 activator Omaveloxolone in primates. Drug Des Devel Ther. 2019;13:1259\u201370.","journal-title":"Drug Des Devel Ther"},{"issue":"2","key":"3588_CR19","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.joca.2018.10.011","volume":"27","author":"G Zheng","year":"2019","unstructured":"Zheng G, Pan Z, Zhan Y, Tang Q, Zheng F, Zhou Y, et al. TFEB protects nucleus pulposus cells against apoptosis and senescence via restoring autophagic flux. Osteoarthritis Cartilage. 2019;27(2):347\u201357.","journal-title":"Osteoarthritis Cartilage"},{"issue":"12","key":"3588_CR20","doi-asserted-by":"publisher","first-page":"10216","DOI":"10.18632\/aging.205920","volume":"16","author":"SK Zheng","year":"2024","unstructured":"Zheng SK, Zhao XK, Wu H, He DW, Xiong L, Cheng XG. Oxidative stress-induced EGR1 upregulation promotes NR4A3-mediated nucleus pulposus cells apoptosis in intervertebral disc degeneration. Aging (Milano). 2024;16(12):10216\u201338.","journal-title":"Aging (Milano)"},{"key":"3588_CR21","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.freeradbiomed.2024.10.001","volume":"225","author":"Y Huang","year":"2024","unstructured":"Huang Y, Sun J, Li S, Shi Y, Yu L, Wu A, et al. Isoliquiritigenin mitigates intervertebral disc degeneration induced by oxidative stress and mitochondrial impairment through a PPAR\u03b3-dependent pathway. Free Radical Biol Med. 2024;225:98\u2013111.","journal-title":"Free Radical Biol Med"},{"key":"3588_CR22","first-page":"83","volume":"36","author":"P Hua","year":"2024","unstructured":"Hua P, Liang R, Yang S, Tu Y, Chen M. Microneedle-assisted dual delivery of PUMA gene and Celastrol for synergistic therapy of rheumatoid arthritis through restoring synovial homeostasis. Bioact Mater. 2024;36:83\u201395.","journal-title":"Bioact Mater"},{"issue":"1","key":"3588_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41413-023-00307-3","volume":"12","author":"EJ Novais","year":"2024","unstructured":"Novais EJ, Narayanan R, Canseco JA, van de Wetering K, Kepler CK, Hilibrand AS, et al. A new perspective on intervertebral disc calcification-from bench to bedside. Bone Res. 2024;12(1):3.","journal-title":"Bone Res"},{"issue":"5","key":"3588_CR24","doi-asserted-by":"publisher","first-page":"e10180","DOI":"10.1002\/jbm4.10180","volume":"3","author":"K Fujii","year":"2019","unstructured":"Fujii K, Yamazaki M, Kang JD, Risbud MV, Cho SK, Qureshi SA, et al. Discogenic back pain: literature review of definition, diagnosis, and treatment. JBMR Plus. 2019;3(5):e10180.","journal-title":"JBMR Plus"},{"issue":"3","key":"3588_CR25","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.spinee.2006.03.008","volume":"7","author":"JR Dimar","year":"2007","unstructured":"Dimar JR, Glassman SD, Carreon LY. Juvenile degenerative disc disease: a report of 76 cases identified by magnetic resonance imaging. Spine J. 2007;7(3):332\u20137.","journal-title":"Spine J"},{"key":"3588_CR26","doi-asserted-by":"publisher","first-page":"592118","DOI":"10.3389\/fbioe.2021.592118","volume":"9","author":"Y Dou","year":"2021","unstructured":"Dou Y, Sun X, Ma X, Zhao X, Yang Q. Intervertebral disk degeneration: the microenvironment and tissue engineering strategies. Front Bioeng Biotechnol. 2021;9:592118.","journal-title":"Front Bioeng Biotechnol"},{"key":"3588_CR27","doi-asserted-by":"publisher","first-page":"109061","DOI":"10.1016\/j.biopha.2019.109061","volume":"117","author":"D Wang","year":"2019","unstructured":"Wang D, Zhu H, Cheng W, Lin S, Shao R, Pan H. Effects of hypoxia and ASIC3 on nucleus pulposus cells: from cell behavior to molecular mechanism. Biomed Pharmacother. 2019;117:109061.","journal-title":"Biomed Pharmacother"},{"issue":"Suppl 2","key":"3588_CR28","doi-asserted-by":"publisher","first-page":"S215","DOI":"10.1007\/s00586-002-0485-8","volume":"11","author":"M Alini","year":"2002","unstructured":"Alini M, Roughley PJ, Antoniou J, Stoll T, Aebi M. A biological approach to treating disc degeneration: not for today, but maybe for tomorrow. Eur Spine J. 2002;11(Suppl 2):S215\u2013220.","journal-title":"Eur Spine J"},{"issue":"7","key":"3588_CR29","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1038\/cdd.2008.65","volume":"15","author":"A Oberst","year":"2008","unstructured":"Oberst A, Bender C, Green DR. Living with death: the evolution of the mitochondrial pathway of apoptosis in animals. Cell Death Differ. 2008;15(7):1139\u201346.","journal-title":"Cell Death Differ"},{"issue":"6662","key":"3588_CR30","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/34214","volume":"391","author":"H Sakahira","year":"1998","unstructured":"Sakahira H, Enari M, Nagata S. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature. 1998;391(6662):96\u20139.","journal-title":"Nature"},{"issue":"Pt B","key":"3588_CR31","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.freeradbiomed.2015.06.021","volume":"88","author":"LE Tebay","year":"2015","unstructured":"Tebay LE, Robertson H, Durant ST, Vitale SR, Penning TM, Dinkova-Kostova AT, et al. Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease. Free Radic Biol Med. 2015;88(Pt B):108\u201346.","journal-title":"Free Radic Biol Med"},{"issue":"6","key":"3588_CR32","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1080\/03008207.2022.2089565","volume":"63","author":"CY Zhang","year":"2022","unstructured":"Zhang CY, Hu XC, Zhang GZ, Liu MQ, Chen HW, Kang XW. Role of Nrf2 and HO-1 in intervertebral disc degeneration. Connect Tissue Res. 2022;63(6):559\u201376.","journal-title":"Connect Tissue Res"},{"issue":"4","key":"3588_CR33","doi-asserted-by":"publisher","first-page":"387","DOI":"10.23876\/j.krcp.20.091","volume":"39","author":"M Nath","year":"2020","unstructured":"Nath M, Agarwal A. New insights into the role of Heme oxygenase-1 in acute kidney injury. Kidney Res Clin Pract. 2020;39(4):387\u2013401.","journal-title":"Kidney Res Clin Pract"},{"issue":"15","key":"3588_CR34","doi-asserted-by":"publisher","first-page":"3628","DOI":"10.3390\/ijms20153628","volume":"20","author":"Y Kishimoto","year":"2019","unstructured":"Kishimoto Y, Kondo K, Momiyama Y. The protective role of Heme Oxygenase-1 in atherosclerotic diseases. Int J Mol Sci. 2019;20(15):3628.","journal-title":"Int J Mol Sci"},{"key":"3588_CR35","doi-asserted-by":"publisher","first-page":"21190","DOI":"10.1038\/srep21190","volume":"6","author":"B Hu","year":"2016","unstructured":"Hu B, Shi C, Xu C, Cao P, Tian Y, Zhang Y, et al. Heme oxygenase-1 attenuates IL-1\u03b2 induced alteration of anabolic and catabolic activities in intervertebral disc degeneration. Sci Rep. 2016;6:21190.","journal-title":"Sci Rep"},{"key":"3588_CR36","doi-asserted-by":"publisher","first-page":"535","DOI":"10.2147\/DDDT.S392535","volume":"17","author":"C Zhang","year":"2023","unstructured":"Zhang C, Lu Z, Lyu C, Zhang S, Wang D. Andrographolide inhibits static mechanical Pressure-Induced intervertebral disc degeneration via the MAPK\/Nrf2\/HO-1 pathway. Drug Des Devel Ther. 2023;17:535\u201350.","journal-title":"Drug Des Devel Ther"},{"issue":"24","key":"3588_CR37","doi-asserted-by":"publisher","first-page":"6275","DOI":"10.3390\/ijms20246275","volume":"20","author":"E Jimi","year":"2019","unstructured":"Jimi E, Fei H, Nakatomi C. NF-\u03baB signaling regulates physiological and pathological chondrogenesis. Int J Mol Sci. 2019;20(24):6275.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"3588_CR38","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1097\/BRS.0000000000000733","volume":"40","author":"S Zhongyi","year":"2015","unstructured":"Zhongyi S, Sai Z, Chao L, Jiwei T. Effects of nuclear factor kappa B signaling pathway in human intervertebral disc degeneration. Spine (Phila Pa 1976). 2015;40(4):224\u201332.","journal-title":"Spine (Phila Pa 1976)"},{"key":"3588_CR39","first-page":"163","volume":"51","author":"S Su","year":"2025","unstructured":"Su S, Wu X, Li B, Zhang F, Zhang K, Wang H, et al. Inhibition of ERK1\/2 mediated activation of Drp1 alleviates intervertebral disc degeneration via suppressing pyroptosis and apoptosis in nucleus pulposus cells. J Orthop Transl. 2025;51:163\u201375.","journal-title":"J Orthop Transl"},{"issue":"11\u201312","key":"3588_CR40","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1007\/s10495-022-01770-9","volume":"27","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Wu J, Teng C, Wang J, Yu J, Jin C, et al. Orientin downregulating oxidative stress-mediated Endoplasmic reticulum stress and mitochondrial dysfunction through AMPK\/SIRT1 pathway in rat nucleus pulposus cells in vitro and attenuated intervertebral disc degeneration in vivo. Apoptosis: Int J Program Cell Death. 2022;27(11\u201312):1031\u201348.","journal-title":"Apoptosis: Int J Program Cell Death"},{"key":"3588_CR41","doi-asserted-by":"publisher","first-page":"122261","DOI":"10.1016\/j.lfs.2023.122261","volume":"335","author":"X Cui","year":"2023","unstructured":"Cui X, Zong S, Song W, Wang C, Liu Y, Zhang L, et al. Omaveloxolone ameliorates cognitive dysfunction in APP\/PS1 mice by stabilizing the STAT3 pathway. Life Sci. 2023;335:122261.","journal-title":"Life Sci"},{"issue":"8","key":"3588_CR42","first-page":"725","volume":"83","author":"A Lee","year":"2023","unstructured":"Lee A, Omaveloxolone. First Approval Drugs. 2023;83(8):725\u20139.","journal-title":"First Approval Drugs"},{"issue":"S1","key":"3588_CR43","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00415-009-1002-3","volume":"256","author":"M Pandolfo","year":"2009","unstructured":"Pandolfo M. Friedreich ataxia: the clinical picture. J Neurol. 2009;256(S1):3\u20138.","journal-title":"J Neurol"},{"issue":"1","key":"3588_CR44","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jns.2011.05.023","volume":"307","author":"AY Tsou","year":"2011","unstructured":"Tsou AY, Paulsen EK, Lagedrost SJ, Perlman SL, Mathews KD, Wilmot GR, et al. Mortality in Friedreich Ataxia. J Neurol Sci. 2011;307(1):46\u20139.","journal-title":"J Neurol Sci"},{"issue":"2","key":"3588_CR45","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.molmed.2023.12.002","volume":"30","author":"F Pilotto","year":"2024","unstructured":"Pilotto F, Chellapandi DM, Puccio H. Omaveloxolone: a groundbreaking milestone as the first FDA-approved drug for Friedreich ataxia. Trends Mol Med. 2024;30(2):117\u201325.","journal-title":"Trends Mol Med"},{"issue":"1","key":"3588_CR46","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/acn3.660","volume":"6","author":"DR Lynch","year":"2019","unstructured":"Lynch DR, Farmer J, Hauser L, Blair IA, Wang QQ, Mesaros C, et al. Safety, pharmacodynamics, and potential benefit of Omaveloxolone in Friedreich ataxia. Ann Clin Transl Neurol. 2019;6(1):15\u201326.","journal-title":"Ann Clin Transl Neurol"},{"issue":"2","key":"3588_CR47","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/ana.25934","volume":"89","author":"DR Lynch","year":"2021","unstructured":"Lynch DR, Chin MP, Delatycki MB, Subramony SH, Corti M, Hoyle JC, et al. Safety and efficacy of Omaveloxolone in Friedreich Ataxia (MOXIe Study). Ann Neurol. 2021;89(2):212\u201325.","journal-title":"Ann Neurol"},{"issue":"2","key":"3588_CR48","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/mds.29286","volume":"38","author":"DR Lynch","year":"2023","unstructured":"Lynch DR, Chin MP, Boesch S, Delatycki MB, Giunti P, Goldsberry A, et al. Efficacy of Omaveloxolone in friedreich\u2019s ataxia: Delayed-Start analysis of the moxie extension. Mov Disord. 2023;38(2):313\u201320.","journal-title":"Mov Disord"},{"issue":"5","key":"3588_CR49","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1093\/brain\/awy071","volume":"141","author":"T Shekh-Ahmad","year":"2018","unstructured":"Shekh-Ahmad T, Eckel R, Dayalan Naidu S, Higgins M, Yamamoto M, Dinkova-Kostova AT, et al. KEAP1 Inhibition is neuroprotective and suppresses the development of epilepsy. Brain. 2018;141(5):1390\u2013403.","journal-title":"Brain"},{"key":"3588_CR50","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3389\/fncel.2018.00188","volume":"12","author":"R Abeti","year":"2018","unstructured":"Abeti R, Baccaro A, Esteras N, Giunti P. Novel Nrf2-Inducer prevents mitochondrial defects and oxidative stress in friedreich\u2019s Ataxia models. Front Cell Neurosci. 2018;12:188.","journal-title":"Front Cell Neurosci"},{"issue":"5","key":"3588_CR51","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1667\/RR13578.1","volume":"181","author":"SA Reisman","year":"2014","unstructured":"Reisman SA, Lee CYI, Meyer CJ, Proksch JW, Sonis ST, Ward KW. Topical application of the synthetic triterpenoid RTA 408 protects mice from radiation-induced dermatitis. Radiat Res. 2014;181(5):512\u201320.","journal-title":"Radiat Res"},{"key":"3588_CR52","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12895-015-0029-7","volume":"15","author":"SA Reisman","year":"2015","unstructured":"Reisman SA, Goldsberry AR, Lee CYI, O\u2019Grady ML, Proksch JW, Ward KW, et al. Topical application of RTA 408 lotion activates Nrf2 in human skin and is well-tolerated by healthy human volunteers. BMC Dermatol. 2015;15:10.","journal-title":"BMC Dermatol"},{"issue":"6","key":"3588_CR53","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1002\/lary.29930","volume":"132","author":"AJ Luginbuhl","year":"2022","unstructured":"Luginbuhl AJ, Hobelmann K, Rodin J, Shukla S, Rodeck U, Linnenbach A. Synthetic triterpenoid RTA-408: limits radiation damage to normal tissue. Laryngoscope. 2022;132(6):1196\u2013204.","journal-title":"Laryngoscope"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-025-03588-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-025-03588-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-025-03588-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T14:02:37Z","timestamp":1750341757000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-025-03588-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,19]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3588"],"URL":"https:\/\/doi.org\/10.1186\/s13075-025-03588-7","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,19]]},"assertion":[{"value":"30 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics statement The Shanghai Public Health Clinical Center Laboratory Animal Welfare & Ethics Committee approved the animal study (No.2022-A018-01).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"128"}}